SK402591A3 - N-PHENYL-N-(4-PIPERIDINYL)AMIDES, PHARMACEUTICAL COMPOSITIONSì (54) CONTAINING THEM AND THEIR USE - Google Patents
N-PHENYL-N-(4-PIPERIDINYL)AMIDES, PHARMACEUTICAL COMPOSITIONSì (54) CONTAINING THEM AND THEIR USE Download PDFInfo
- Publication number
- SK402591A3 SK402591A3 SK4025-91A SK402591A SK402591A3 SK 402591 A3 SK402591 A3 SK 402591A3 SK 402591 A SK402591 A SK 402591A SK 402591 A3 SK402591 A3 SK 402591A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- piperidine
- phenyl
- phenylamino
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31131189A | 1989-02-15 | 1989-02-15 | |
US07/448,497 US5019583A (en) | 1989-02-15 | 1989-12-11 | N-phenyl-N-(4-piperidinyl)amides useful as analgesics |
Publications (1)
Publication Number | Publication Date |
---|---|
SK402591A3 true SK402591A3 (en) | 2000-09-12 |
Family
ID=26977841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK4025-91A SK402591A3 (en) | 1989-02-15 | 1991-12-23 | N-PHENYL-N-(4-PIPERIDINYL)AMIDES, PHARMACEUTICAL COMPOSITIONSì (54) CONTAINING THEM AND THEIR USE |
Country Status (22)
Country | Link |
---|---|
US (1) | US5019583A (da) |
EP (1) | EP0383579B1 (da) |
JP (1) | JP2895145B2 (da) |
KR (1) | KR0160979B1 (da) |
AT (1) | ATE140451T1 (da) |
AU (1) | AU636330B2 (da) |
CA (1) | CA2010011C (da) |
CY (1) | CY2002A (da) |
CZ (1) | CZ402591A3 (da) |
DE (2) | DE19675028I2 (da) |
DK (1) | DK0383579T3 (da) |
ES (1) | ES2088961T4 (da) |
GR (1) | GR3020719T3 (da) |
HK (1) | HK78297A (da) |
IE (1) | IE77156B1 (da) |
LU (1) | LU90011I2 (da) |
MX (1) | MX9203024A (da) |
NL (1) | NL960030I2 (da) |
NZ (1) | NZ232542A (da) |
PT (1) | PT93137B (da) |
SG (1) | SG47967A1 (da) |
SK (1) | SK402591A3 (da) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5214148A (en) * | 1990-12-18 | 1993-05-25 | Glaxo Inc. | Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides |
US5130321A (en) * | 1990-12-18 | 1992-07-14 | Glaxo Inc. | Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides |
GB9316863D0 (en) * | 1993-08-13 | 1993-09-29 | Glaxo Group Ltd | Chemical process |
US5466700A (en) * | 1993-08-30 | 1995-11-14 | Glaxo Wellcome Inc. | Anesthetic use of N-phenyl-N-(4-piperidinyl)amides |
US5866591A (en) * | 1996-09-11 | 1999-02-02 | Glaxo Wellcome Inc. | Stable formulations of remifentanil |
CA2316341A1 (en) * | 1997-12-24 | 1999-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
US6858018B1 (en) | 1998-09-28 | 2005-02-22 | Vyteris, Inc. | Iontophoretic devices |
US6436959B1 (en) | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
US7074935B2 (en) | 1999-12-06 | 2006-07-11 | Mallinckrodt Inc. | Methods for the syntheses of alfentanil, sufentanil and remifentanil |
US6476050B2 (en) | 2000-03-14 | 2002-11-05 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
US8017627B2 (en) * | 2000-07-31 | 2011-09-13 | Nycomed Danmark Aps | Fentanyl composition for nasal administration |
CA2443350A1 (en) * | 2001-04-03 | 2002-12-05 | Aryx Therapeutics | Ultrashort-acting opioids for transdermal application |
AU2002361709A1 (en) * | 2001-12-17 | 2003-06-30 | Aryx Therapeutics | Analgesic delivery systems and methods of use |
WO2005030722A1 (ja) * | 2003-09-29 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | N-置換-n-(4-ピペリジニル)アミド誘導体 |
JP2008502651A (ja) | 2004-06-18 | 2008-01-31 | ノイロサーチ アクティーゼルスカブ | モノアミン神経伝達物質再取込み阻害剤としての、新規アルキル置換ピペリジン誘導体及びその使用 |
JPWO2006030931A1 (ja) * | 2004-09-14 | 2008-05-15 | 日本ケミファ株式会社 | N−置換−n−(4−ピペリジニル)アミド誘導体 |
AU2006317591A1 (en) * | 2005-11-17 | 2007-05-31 | Mallinckrodt Inc. | Process for synthesizing remifentanil |
JP2009524659A (ja) * | 2006-01-24 | 2009-07-02 | マリンクロッド・インコーポレイテッド | レミフェンタニルの合成方法 |
JP2009525329A (ja) * | 2006-02-03 | 2009-07-09 | マリンクロッド・インコーポレイテッド | レミフェンタニル塩酸塩の結晶形 |
EP1867635A1 (en) * | 2006-06-15 | 2007-12-19 | Kern Pharma, S.L. | Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation |
GB0613693D0 (en) * | 2006-07-10 | 2006-08-16 | Cenes Ltd | Benzodiazepine salts (3) |
PL2081921T3 (pl) | 2006-07-10 | 2011-03-31 | Paion Uk Ltd | Krótko działające sole benzodiazepiny i ich formy polimorficzne |
WO2008045192A2 (en) * | 2006-10-05 | 2008-04-17 | Mallinckrodt Inc. | Alternate process for remifentanil preparation |
CA2670704A1 (en) * | 2006-11-29 | 2008-06-05 | Mallinckrodt Inc. | New process for remifentanil synthesis |
MX2010010675A (es) | 2008-03-31 | 2010-11-25 | Gen Hospital Corp | Analogos de etomidato con propiedades farmacocineticas y farmacodinamicas mejoradas. |
US20110144346A1 (en) * | 2008-07-03 | 2011-06-16 | Cilag Ag | Method for producing n-phenyl-n-(4-piperidinyl) amide salts |
US8299258B2 (en) * | 2008-11-04 | 2012-10-30 | Cambrex Charles City | Method of making piperidine derivatives |
EP2451779B1 (en) | 2009-07-10 | 2014-09-03 | The General Hospital Corporation | Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
EP2450039A1 (en) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosing regimen for sedation with CNS 7056 (Remimazolam) |
DK2802325T3 (da) | 2012-01-13 | 2017-03-13 | Massachusetts Gen Hospital | Anæstetiske forbindelser og relaterede anvendelser deraf |
AU2013328280B2 (en) | 2012-10-08 | 2017-12-21 | Auckland Uniservices Limited | Ketamine derivatives |
AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
CN103728403B (zh) * | 2013-08-30 | 2015-10-07 | 宜昌人福药业有限责任公司 | 一种盐酸瑞芬太尼原料药中有关物质的检测方法 |
DK3199523T3 (da) | 2016-01-29 | 2018-11-26 | Bioka S R O | Ny fremgangsmåde til fremstilling af n-phenyl-n-(4-piperidinyl)-amidderivater, såsom remifentanil og carfentanil |
SI3643704T1 (sl) | 2018-10-26 | 2021-04-30 | Hameln Pharma Gmbh | Novi intermediati za pripravo remifentanil hidroklorida |
GB202010168D0 (en) * | 2020-07-02 | 2020-08-19 | Johnson Matthey Plc | Process for preparing remifentanil hydrochloride |
CN114262320A (zh) * | 2021-12-28 | 2022-04-01 | 宜昌人福药业有限责任公司 | 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE623427A (da) * | 1961-10-10 | |||
US3655675A (en) * | 1968-09-09 | 1972-04-11 | Sterling Drug Inc | N-(n-heteryl)-acylanilides |
US4179569A (en) * | 1975-03-14 | 1979-12-18 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-N-phenylamides |
US3998834A (en) * | 1975-03-14 | 1976-12-21 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-n-phenylamides and -carbamates |
US4167574A (en) * | 1978-03-13 | 1979-09-11 | Janssen Pharmaceutica, N.V. | N-phenyl-N-(4-piperidinyl)amides |
US4584303A (en) * | 1984-04-09 | 1986-04-22 | The Boc Group, Inc. | N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds |
US4801721A (en) * | 1984-08-16 | 1989-01-31 | Ryan James W | Stereospecific synthesis of carboxyalkyl peptides |
CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
-
1989
- 1989-12-11 US US07/448,497 patent/US5019583A/en not_active Expired - Lifetime
-
1990
- 1990-02-14 EP EP90301586A patent/EP0383579B1/en not_active Expired - Lifetime
- 1990-02-14 DE DE1996175028 patent/DE19675028I2/de active Active
- 1990-02-14 DE DE69027794T patent/DE69027794T2/de not_active Expired - Lifetime
- 1990-02-14 DK DK90301586.5T patent/DK0383579T3/da active
- 1990-02-14 KR KR1019900001796A patent/KR0160979B1/ko not_active IP Right Cessation
- 1990-02-14 NZ NZ232542A patent/NZ232542A/en unknown
- 1990-02-14 SG SG1996005735A patent/SG47967A1/en unknown
- 1990-02-14 PT PT93137A patent/PT93137B/pt not_active IP Right Cessation
- 1990-02-14 IE IE53290A patent/IE77156B1/en not_active IP Right Cessation
- 1990-02-14 CA CA002010011A patent/CA2010011C/en not_active Expired - Fee Related
- 1990-02-14 AT AT90301586T patent/ATE140451T1/de active
- 1990-02-14 JP JP2031680A patent/JP2895145B2/ja not_active Expired - Lifetime
- 1990-02-14 ES ES90301586T patent/ES2088961T4/es not_active Expired - Lifetime
- 1990-02-14 AU AU49731/90A patent/AU636330B2/en not_active Expired
-
1991
- 1991-12-23 SK SK4025-91A patent/SK402591A3/sk unknown
- 1991-12-23 CZ CS914025A patent/CZ402591A3/cs unknown
-
1992
- 1992-06-19 MX MX9203024A patent/MX9203024A/es unknown
-
1996
- 1996-08-02 GR GR960402083T patent/GR3020719T3/el unknown
- 1996-11-21 NL NL960030C patent/NL960030I2/nl unknown
-
1997
- 1997-01-24 LU LU90011C patent/LU90011I2/fr unknown
- 1997-06-12 HK HK78297A patent/HK78297A/xx not_active IP Right Cessation
- 1997-12-05 CY CY200297A patent/CY2002A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69027794T2 (de) | 1997-01-02 |
IE77156B1 (en) | 1997-12-03 |
NL960030I1 (nl) | 1997-02-03 |
NZ232542A (en) | 1992-06-25 |
NL960030I2 (nl) | 1997-05-01 |
ES2088961T3 (es) | 1996-10-01 |
ATE140451T1 (de) | 1996-08-15 |
IE900532L (en) | 1990-08-15 |
KR900012906A (ko) | 1990-09-03 |
AU4973190A (en) | 1990-08-23 |
CY2002A (en) | 1997-12-05 |
EP0383579A1 (en) | 1990-08-22 |
LU90011I2 (fr) | 1997-03-11 |
US5019583A (en) | 1991-05-28 |
CZ402591A3 (en) | 1993-04-14 |
KR0160979B1 (ko) | 1998-12-01 |
PT93137A (pt) | 1990-08-31 |
CA2010011A1 (en) | 1990-08-15 |
HK78297A (en) | 1997-06-20 |
DK0383579T3 (da) | 1996-10-14 |
JPH02300167A (ja) | 1990-12-12 |
GR3020719T3 (en) | 1996-11-30 |
JP2895145B2 (ja) | 1999-05-24 |
DE69027794D1 (de) | 1996-08-22 |
AU636330B2 (en) | 1993-04-29 |
ES2088961T4 (es) | 1996-12-01 |
EP0383579B1 (en) | 1996-07-17 |
PT93137B (pt) | 1996-02-29 |
DE19675028I2 (de) | 2002-11-07 |
SG47967A1 (en) | 1998-04-17 |
CA2010011C (en) | 1997-12-02 |
MX9203024A (es) | 1992-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK402591A3 (en) | N-PHENYL-N-(4-PIPERIDINYL)AMIDES, PHARMACEUTICAL COMPOSITIONSì (54) CONTAINING THEM AND THEIR USE | |
Feldman et al. | Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgesics | |
JP3833116B2 (ja) | ビフェニル誘導体、その製法及び薬剤としての使用 | |
RU2396257C2 (ru) | Производные 4-аминопиперидина | |
US6790854B2 (en) | Diphenylalkylamine derivatives useful as opioid receptor agonists | |
US4929618A (en) | Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same | |
US5814636A (en) | Compounds with platelet aggregation inhibitor activity | |
PT1891029E (pt) | Compostos orgânicos para o tratamento de condições inflamatórias ou alérgicas | |
CZ316497A3 (cs) | Nové heterocyklické sloučeniny | |
EP1201239A1 (en) | Cyclic amine ccr3 antagonists | |
JP2008063256A (ja) | β‐アミノ酸誘導体 | |
US6391890B1 (en) | Heterocyclic compounds | |
SK12152003A3 (sk) | Bifenylkarboxamidy znižujúce hladinu lipidov | |
KR20020065916A (ko) | Mtp 억제제로서 치환된 피페라진 유도체 | |
JPH0552834B2 (da) | ||
US5214148A (en) | Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides | |
EP1542683B1 (en) | Calcium channel blockers | |
JPWO2006030931A1 (ja) | N−置換−n−(4−ピペリジニル)アミド誘導体 | |
JP2007512382A (ja) | δ−アミノ−γ−ヒドロキシ−ω−アリール−アルカン酸アミドおよびレニン阻害剤としての使用 | |
US6239148B1 (en) | N-substituted azaheterocyclic carboxylic acids and esters thereof | |
US5130321A (en) | Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides | |
HU211916A9 (hu) | Érzéstelenítőként alkalmazható N-fenil-N-(4-piperidinil)-amidok Az átmeneti oltalom az 1-29., 39., 46. és 47. igénypontra vonatkozik. | |
AU6996194A (en) | N-substituted azaheterocyclic carboxylic acids and esters thereof | |
JPH041193A (ja) | ピペリジン誘導体 |